Trial Details
COMPLETEDBasic Information
| Clinical ID | c4733 |
|---|---|
| Identifier | NCT00055497 |
| Trial Title | Remission in Subjects With Crohn's Disease, 1 Year Phase |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Double-blind (DB) adalimumab placebo|BIOLOGICAL: DB adalimumab 40 mg eow|BIOLOGICAL: DB adalimumab 40 mg ew|BIOLOGICAL: OL adalimumab 40 mg |
Participant Information
| Sponsor | Abbott |
|---|---|
| City | Berkeley |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2002-08 |
|---|---|
| Primary Completion Date | 2005-01 |
| Completion Date | 2008-12 |